Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 22% ± 1% | |
abnormal cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of DEDD at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 2122.19 | 21 / 21 | 100% | 43.69 | 504 / 504 |
esophagus | 100% | 2054.76 | 1445 / 1445 | 100% | 31.56 | 183 / 183 |
intestine | 100% | 2107.50 | 966 / 966 | 100% | 28.30 | 527 / 527 |
liver | 100% | 1066.25 | 226 / 226 | 100% | 30.15 | 406 / 406 |
ovary | 100% | 2085.21 | 180 / 180 | 100% | 37.71 | 430 / 430 |
pancreas | 100% | 981.48 | 328 / 328 | 100% | 36.16 | 178 / 178 |
prostate | 100% | 1948.27 | 245 / 245 | 100% | 30.39 | 502 / 502 |
skin | 100% | 2049.25 | 1809 / 1809 | 100% | 34.10 | 472 / 472 |
stomach | 100% | 1472.67 | 359 / 359 | 100% | 27.18 | 286 / 286 |
thymus | 100% | 2060.36 | 653 / 653 | 100% | 30.18 | 605 / 605 |
uterus | 100% | 2037.02 | 170 / 170 | 100% | 42.73 | 459 / 459 |
lung | 100% | 2216.20 | 578 / 578 | 100% | 35.92 | 1154 / 1155 |
brain | 100% | 1252.73 | 2635 / 2642 | 100% | 34.78 | 705 / 705 |
breast | 100% | 2325.31 | 459 / 459 | 100% | 47.73 | 1114 / 1118 |
adrenal gland | 100% | 1666.22 | 258 / 258 | 99% | 23.91 | 228 / 230 |
kidney | 100% | 1552.03 | 89 / 89 | 99% | 24.55 | 889 / 901 |
adipose | 100% | 2523.88 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2153.20 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 23.07 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 33.59 | 29 / 29 |
muscle | 100% | 2368.77 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2282.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 33.23 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.20 | 1 / 1 |
peripheral blood | 100% | 2213.41 | 926 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 1191.53 | 855 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042177 | Biological process | negative regulation of protein catabolic process |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0007283 | Biological process | spermatogenesis |
GO_1901837 | Biological process | negative regulation of transcription of nucleolar large rRNA by RNA polymerase I |
GO_0046697 | Biological process | decidualization |
GO_0005730 | Cellular component | nucleolus |
GO_0005737 | Cellular component | cytoplasm |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DEDD |
Protein name | Death effector domain-containing protein (DEDPro1) (Death effector domain-containing testicular molecule) (FLDED-1) Death effector domain containing |
Synonyms | KE05 DEDPRO1 hCG_20845 DEFT |
Description | FUNCTION: A scaffold protein that directs CASP3 to certain substrates and facilitates their ordered degradation during apoptosis. May also play a role in mediating CASP3 cleavage of KRT18. Regulates degradation of intermediate filaments during apoptosis. May play a role in the general transcription machinery in the nucleus and might be an important regulator of the activity of GTF3C3. Inhibits DNA transcription in vitro (By similarity). . |
Accessions | O75618 ENST00000368005.5 ENST00000458050.6 [O75618-1] ENST00000368006.8 [O75618-1] ENST00000545495.5 [O75618-1] ENST00000490843.6 [O75618-1] B1AQP5 ENST00000464113.1 V9GY27 |